Sintecabio ranked among the top searched stocks for 10 days in the past month.


As of 1:31 PM on the 6th, Sintecabio is trading at 42,300 KRW, up 0.12% from the previous day. This marks a 124.4% increase compared to September 3. Sintecabio is known as a genomic big data research company.

Today, foreigners are tentatively recorded as net sellers of 6,000 shares. Over the past five days, individual investors have net bought 67,944 shares, while foreigners and institutions have net sold 76,912 shares and 5,726 shares, respectively.


On September 29, Sintecabio became a market issue with the headline "COVID-19 treatment efficacy Remdesivir doubled, hitting the upper price limit."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing